WALTHAM, Mass and DUBLIN, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered therapies ...
After hours: March 5 at 4:36:35 PM EST Loading Chart for MURA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback